Double maintains 3 strategies that include NVAX - Novavax, Inc.
Current Value
$7.101 Year Return
Current Value
$7.101 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMNN | -19.38% | $7.29M | -71.34% | 0.00% |
CME | -13.87% | $101.62B | +32.97% | 3.72% |
LITB | -12.46% | $25.74M | -66.23% | 0.00% |
KR | -11.71% | $45.24B | +27.46% | 1.85% |
ED | -9.14% | $37.26B | +10.17% | 3.23% |
CBOE | -7.77% | $23.92B | +26.61% | 1.07% |
BTCT | -7.64% | $26.77M | +103.92% | 0.00% |
VHC | -7.64% | $33.82M | +73.48% | 0.00% |
COR | -7.35% | $56.23B | +31.98% | 0.74% |
KO | -7.34% | $306.21B | +14.58% | 2.75% |
EXC | -6.81% | $43.83B | +17.26% | 3.57% |
QNRX | -6.78% | $4.98M | -66.39% | 0.00% |
AEP | -6.64% | $54.38B | +14.02% | 3.57% |
AJG | -6.59% | $85.92B | +33.68% | 0.73% |
EVRG | -6.45% | $15.17B | +23.42% | 3.02% |
MSIF | -6.29% | $721.85M | +29.60% | 6.99% |
XEL | -5.76% | $39.92B | +28.05% | 3.19% |
COLL | -5.72% | $926.34M | -14.78% | 0.00% |
ICFI | -5.45% | $1.62B | -38.32% | 0.65% |
WM | -5.23% | $93.89B | +11.38% | 1.31% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BNTX | 47.37% | $23.82B | +0.07% | 0.00% |
MRNA | 46.23% | $10.33B | -83.71% | 0.00% |
EBS | 42.15% | $352.81M | +31.58% | 0.00% |
CVAC | 42.06% | $936.65M | +4.79% | 0.00% |
ARCT | 41.17% | $347.14M | -58.99% | 0.00% |
CRSP | 40.34% | $3.24B | -32.66% | 0.00% |
TWST | 38.30% | $1.69B | -31.91% | 0.00% |
HZO | 37.29% | $461.89M | -20.45% | 0.00% |
OLED | 37.06% | $6.92B | -16.55% | 1.17% |
ONEW | 36.81% | $228.71M | -43.03% | 0.00% |
JOBY | 36.33% | $5.26B | +38.05% | 0.00% |
CRSR | 36.13% | $880.43M | -25.65% | 0.00% |
XNCR | 36.12% | $547.30M | -67.62% | 0.00% |
PGEN | 35.89% | $410.30M | +3.73% | 0.00% |
KLIC | 35.66% | $1.70B | -30.35% | 2.58% |
DHR | 35.03% | $134.17B | -28.28% | 0.61% |
FDMT | 34.95% | $166.77M | -85.69% | 0.00% |
COHU | 34.79% | $803.57M | -44.33% | 0.00% |
CTS | 34.74% | $1.21B | -22.56% | 0.40% |
PDSB | 34.37% | $71.76M | -49.68% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
COMT | -0.07% | $597.99M | 0.48% |
USCI | -0.15% | $230.01M | 1.07% |
DBC | 0.30% | $1.16B | 0.87% |
UTWO | -0.38% | $384.90M | 0.15% |
DUSB | 0.46% | $1.21B | 0.15% |
PDBC | 0.46% | $4.39B | 0.59% |
KMLM | -0.53% | $190.16M | 0.9% |
FTSM | -0.56% | $6.48B | 0.45% |
FTSD | 0.56% | $212.66M | 0.25% |
DFNM | 0.56% | $1.54B | 0.17% |
IBD | -0.62% | $381.89M | 0.43% |
MEAR | -0.74% | $1.04B | 0.25% |
OILK | -0.82% | $61.94M | 0.69% |
CARY | 0.90% | $347.36M | 0.8% |
LDUR | -0.96% | $909.54M | 0.5% |
FXC | -0.97% | $87.64M | 0.4% |
FLMI | 1.04% | $669.33M | 0.3% |
BAR | 1.06% | $1.11B | 0.1749% |
IBDQ | 1.07% | $3.07B | 0.1% |
UGA | -1.09% | $72.78M | 0.97% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 45.18% | $5.19B | 0.35% |
GNOM | 44.84% | $42.14M | 0.5% |
ARKG | 43.57% | $920.94M | 0.75% |
IBB | 41.56% | $5.41B | 0.45% |
PBE | 40.17% | $224.25M | 0.58% |
BBH | 38.35% | $340.78M | 0.35% |
FBT | 36.97% | $1.05B | 0.56% |
IWC | 36.39% | $784.94M | 0.6% |
IWO | 35.55% | $11.41B | 0.24% |
XSD | 34.86% | $1.20B | 0.35% |
IWM | 34.31% | $65.60B | 0.19% |
VTWO | 34.26% | $12.14B | 0.07% |
CPRJ | 34.20% | $47.84M | 0.69% |
CWB | 33.94% | $3.82B | 0.4% |
KOMP | 33.92% | $2.19B | 0.2% |
QQQJ | 33.79% | $615.86M | 0.15% |
SCHA | 33.79% | $16.91B | 0.04% |
XRT | 33.70% | $356.04M | 0.35% |
KJUL | 33.55% | $114.84M | 0.79% |
ICVT | 33.34% | $2.47B | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -28.75% | $360.65M | 1.43% |
VIXY | -23.22% | $126.83M | 0.85% |
TAIL | -16.71% | $118.71M | 0.59% |
IBMN | -12.79% | $447.74M | 0.18% |
IVOL | -10.99% | $355.73M | 1.02% |
ULST | -9.96% | $638.58M | 0.2% |
CTA | -9.80% | $1.08B | 0.76% |
CLIP | -9.65% | $1.51B | 0.07% |
FXY | -8.59% | $857.57M | 0.4% |
AGZD | -7.69% | $109.45M | 0.23% |
BILZ | -7.67% | $871.57M | 0.14% |
GSST | -7.66% | $878.39M | 0.16% |
TFLO | -7.59% | $7.03B | 0.15% |
CMBS | -6.73% | $431.43M | 0.25% |
TBIL | -5.06% | $5.81B | 0.15% |
SHYM | -5.03% | $323.08M | 0.35% |
USFR | -4.69% | $18.91B | 0.15% |
KCCA | -4.59% | $95.01M | 0.87% |
GBIL | -4.46% | $6.06B | 0.12% |
ICLO | -4.34% | $304.64M | 0.19% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CLMT | -0.04% | $1.22B | -8.60% | 0.00% |
CREG | -0.08% | $16.90M | -40.55% | 0.00% |
PNW | 0.10% | $10.73B | +17.53% | 3.94% |
TMUS | 0.11% | $273.44B | +45.98% | 1.27% |
AU | 0.12% | $21.59B | +81.08% | 2.05% |
RSG | -0.15% | $78.44B | +34.71% | 0.91% |
WELL | -0.17% | $96.07B | +46.96% | 1.80% |
SRRK | 0.19% | $2.89B | +182.30% | 0.00% |
KMB | 0.21% | $46.37B | +6.00% | 3.51% |
FNV | 0.24% | $31.60B | +35.30% | 0.88% |
ALTO | 0.24% | $70.88M | -41.53% | 0.00% |
SFM | 0.27% | $15.83B | +100.48% | 0.00% |
VSA | 0.28% | $6.72M | -45.11% | 0.00% |
HMY | 0.35% | $9.44B | +66.08% | 1.10% |
KDP | -0.37% | $44.83B | -2.85% | 2.75% |
SAFT | 0.40% | $1.22B | +6.60% | 4.42% |
GIS | -0.42% | $29.20B | -22.80% | 4.50% |
NEXA | -0.42% | $707.22M | -31.45% | 0.00% |
CALM | -0.44% | $5.06B | +59.12% | 7.10% |
AMBC | -0.45% | $361.21M | -55.05% | 0.00% |
Yahoo
BMRN and NVAX are in the spotlight this week following announcement agreement and regulatory update.
Yahoo
Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.
Finnhub
WASHINGTON — Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has...
Yahoo
On May 20, BofA analyst Alec Stranahan reiterated a Hold rating on Novavax, Inc. (NASDAQ:NVAX) stock, setting a price target of $10. The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from Sanofi during Q3 and an additional $50 million in the second half of […]
SeekingAlpha
Novavax secures full FDA approval for NUVAXOVID, unlocking a $175M Sanofi payment.
Yahoo
The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots. Moderna (MRNA) and Pfizer (PFE) shares move higher on this news, while Novavax (NVAX) takes a dip. D-Wave Quantum (QBTS) sees over 26% of stock gains ahead of Tuesday's market close after unveiling its Advantage 2 quantum computer. Cruiseline operator Viking Holdings (VIK) stock takes a hit today despite the company sharing strong first quarter earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.